SoftBank’s Vision Fund backs Pear Therapeutics in $80M VC round to forge new market paths for digital treatment apps
Pear Therapeutics, developer of prescription apps to treat addiction and insomnia, has landed $80 million through a venture capital round led by SoftBank’s Vision Fund 2.